CIK 0001453687
- Non-accelerated filer
- Smaller reporting company
Cartesian Therapeutics, Inc.
Sign in to watch- Ticker
- RNAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 301-348-8698
- Business address
- 7495 NEW HORIZON WAY, FREDERICK, MD, 21703
- Former names
- SELECTA BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-04 | Johnston Lloyd P. COO and SVP, R&D | Grant or award · Employee Stock Option (right to buy) | +230,000 | 230,000 | ||
| 2021-01-04 | Dahms Bradford D. Chief Financial Officer | Grant or award | +38,000 | 38,000 | ||
| 2021-01-04 | Dahms Bradford D. Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +230,000 | 230,000 | ||
| 2021-01-04 | Brunn Carsten President and CEO | Grant or award | +110,000 | 211,350 | ||
| 2021-01-04 | Brunn Carsten President and CEO | Grant or award · Employee Stock Option (right to buy) | +670,000 | 670,000 | ||
| 2020-12-14 | TRABER PETER G Chief Medical Officer | Purchase | +40,000 | $3.24 | $129K | 40,000 |
| 2020-12-02 | Brunn Carsten President and CEO | Sale | −3,323 | $3.35 | $11K | 101,350 |
| 2020-12-01 | Brunn Carsten President and CEO | Exercise or conversion | +10,938 | 104,673 | ||
| 2020-12-01 | Brunn Carsten President and CEO | Exercise or conversion · Restricted Stock Units | −10,938 | 87,500 | ||
| 2020-10-23 | Kishimoto Takashi Kei Chief Scientific Officer | Exercise or conversion | +30,000 | $2.77 | $83K | 126,149 |
| 2020-10-23 | Kishimoto Takashi Kei Chief Scientific Officer | Exercise or conversion · Employee Stock Option (right to buy) | −30,000 | 13,629 | ||
| 2020-10-23 | SPRINGER TIMOTHY A Director | Purchase | +994,488 | $2.71 | $2.7M | 14,480,948 |
| 2020-10-22 | SPRINGER TIMOTHY A Director | Purchase | +1,770,204 | $2.63 | $4.7M | 13,486,460 |
| 2020-10-21 | SPRINGER TIMOTHY A Director | Purchase | +880,000 | $2.50 | $2.2M | 11,716,256 |
| 2020-10-20 | SPRINGER TIMOTHY A Director | Purchase | +910,000 | $2.21 | $2.0M | 10,836,256 |
| 2020-10-19 | SPRINGER TIMOTHY A Director | Purchase | +759,500 | $2.36 | $1.8M | 9,926,256 |
| 2020-10-16 | SPRINGER TIMOTHY A Director | Purchase | +218,196 | $2.42 | $528K | 9,166,756 |
| 2020-10-09 | SPRINGER TIMOTHY A Director | Purchase | +276,703 | $2.00 | $552K | 8,948,560 |
| 2020-10-08 | SPRINGER TIMOTHY A Director | Purchase | +530,441 | $1.89 | $1.0M | 8,671,857 |
| 2020-10-07 | SPRINGER TIMOTHY A Director | Purchase | +654,953 | $1.65 | $1.1M | 8,141,416 |
Page 26 of 32 · 631 trades